Here, we showed that FGFC1 could selectively inhibit the expressions of p-EGFR, p-PI3K, p-Akt, and p-mTOR in erlotinib-resistant H1975 NSCLC cells (Figures 4A,B). This evidence concerns the gene EGFR and non-small cell lung carcinoma.